ESTA$64.51
Chart
Performance
Key Stats
AI ESTA Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyEstablishment Labs Holdings Inc. shows strong fundamental growth, supported by a positive outlook in the medical technology sector. Technical indicators are mixed, suggesting a potential short-term consolidation, while thematic alignment is moderate.
Thematic
The company operates in the medical technology sector, focusing on aesthetic and reconstructive surgeries, which has moderate growth potential. Its specific niche in breast implants positions it within a stable, albeit competitive, market segment.
Fundamental
The company exhibits solid revenue growth and improving profitability metrics, though it carries a significant debt burden. Its cash flow generation is currently negative, requiring careful management.
Technical
The stock price is currently trading below key moving averages, indicating a bearish short-term trend. However, some oscillators suggest potential for a rebound from oversold levels.
| Factor | Score |
|---|---|
| Medical Technology Advancement | 70 |
| Aging Population and Aesthetics | 75 |
| Healthcare Regulations | 50 |
| Global Market Expansion | 60 |
| Competition | 50 |
| Factor | Score |
|---|---|
| Valuation | 60 |
| Profitability | 30 |
| Growth | 85 |
| Balance Sheet Health | 40 |
| Cash Flow | 35 |
| Factor | Score |
|---|---|
| Trend Analysis | 40 |
| Momentum | 45 |
| Volume Confirmation | 50 |
| Support & Resistance | 60 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Positive Medium-Term Performance
The stock has shown positive performance over the last 1 month (14.15%) and 6 months (21.37%), indicating a recent upward trend.
Positive Price-to-Sales Ratio Trend
The Price-to-Sales (PS) ratio has shown a general downward trend from 15.4 in 2021 to 8.0 in 2024, suggesting potential value.
Bearish Points (8)
Negative Earnings Per Share (EPS)
The company has consistently reported negative EPS, with EPS TTM at -3.12, and a negative net income of -71.92M in TTM.
Negative Net Margins
The company has consistently reported negative net margins, with the latest quarterly net margin at -77.6% (Q4 2024) and an annual net margin of -51.0% in 2024.
Calendar
August 2025
4
Next Earnings Date
H: $-0.52
A: $-0.56
L: $-0.60
H: 52.10M
A: 51.10M
L: 50.70M
Profile
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Seasonals
Price Target
56.25 USD
The 39 analysts offering 1 year price forecasts for ESTA have a max estimate of 70.00 and a min estimate of 45.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
Operates major online travel agencies (Booking.com, Priceline, Kayak) widely used by international travelers planning trips to the US, many of whom require ESTA.
Weight: 93
A leading online travel agency (Expedia, Hotels.com, Vrbo) serving a vast international clientele traveling to the US, often requiring ESTA for entry.
Weight: 90
A primary global credit card network used for processing the required ESTA application fee, directly involved in the transaction process.
Weight: 88
Another major global credit card network, essential for processing ESTA application fees, facilitating payment for travel authorization.